Key result
The provided text contains only author affiliations and lacks quantitative clinical data regarding the cardiac toxicity of vascular-disrupting agents.
Design
Editorial
Authors
Loading...
Highlights the need for collaboration between oncologists and cardiologists to manage the cardiac toxicity of new vascular-disrupting agents.
Highlights the need for collaboration between oncologists and cardiologists to manage the cardiac toxicity of new vascular-disrupting agents.
Heeckeren et al. (2006) conducted an editorial in Cardiac toxicity. Vascular-disrupting agents was evaluated. The provided text contains only author affiliations and lacks quantitative clinical data regarding the cardiac toxicity of vascular-disrupting agents.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: